Not applicableEnded earlyNCT01946100What this trial is testingTreatment of Multifocal Lung AdenocarcinomaWho this might be right forLung NeoplasmsCarcinoma Non-small-cell LungAdenocarcinoma Mayo Clinic 100
Not applicableLooking for participantsNCT07224464What this trial is testingThe Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.Who this might be right forMetastatic Solid TumorsStage 4 Cancer New Phase Ltd. 12
Early research (Phase 1)Looking for participantsNCT04282044What this trial is testingStudy of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesWho this might be right forSolid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more BioEclipse Therapeutics 60
Large-scale testing (Phase 3)UnknownNCT02929693What this trial is testingClinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary AdenocarcinomaWho this might be right forCancer Shanghai University of Traditional Chinese Medicine 198
Not applicableUnknownNCT04452058What this trial is testingCT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLCWho this might be right forPredictive Cancer ModelLung CancerPreinvasive Adenocarcinoma Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 500
Not applicableWithdrawnNCT02891733What this trial is testingRetrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung AdenocarcinomasWho this might be right forMetastatic Lung Adenocarcinomas Fondation Hôpital Saint-Joseph
Not applicableLooking for participantsNCT07751783What this trial is testingDevelopment and Dissemination of Exercise Prescription and Intervention for Cancer PopulationsWho this might be right forCancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Lung Cancer (Non-Small Cell)+2 more Kaohsiung Medical University Chung-Ho Memorial Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00003666What this trial is testingIrofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 36
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Looking for participantsNCT06472388What this trial is testingEverolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1+4 more AC Camargo Cancer Center 100
Not applicableLooking for participantsNCT06349642What this trial is testingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformWho this might be right forEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more Mayo Clinic 324
Testing effectiveness (Phase 2)WithdrawnNCT02763761What this trial is testingAn Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or OpdivoWho this might be right forRenal Cell CarcinomaMelanomaLung Cancer Bristol-Myers Squibb
Testing effectiveness (Phase 2)Looking for participantsNCT06859684What this trial is testingHepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)Who this might be right forIntrahepatic Cholangiocarcinoma (Icc)HAICDurvalumab West China Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT04591002What this trial is testingOsimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)Who this might be right forLung Cancer Samsung Medical Center 43
Very early researchLooking for participantsNCT07235280What this trial is testingTesting the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung AdenocarcinomaWho this might be right forLung AdenocarcinomaStage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8Stage IA2 Lung Cancer AJCC v8+2 more Jonsson Comprehensive Cancer Center 48
Testing effectiveness (Phase 2)UnknownNCT04631731What this trial is testingRisk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin ToxicityWho this might be right forLung Cancer, Nonsmall CellRenal Cell CarcinomaMelanoma+4 more Western Sydney Local Health District 200
Testing effectiveness (Phase 2)Looking for participantsNCT03351842What this trial is testingSurgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%Who this might be right forChemotherapy, AdjuvantLung Adenocarcinoma, Stage ITreatment+1 more Shanghai Pulmonary Hospital, Shanghai, China 460
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793253What this trial is testingPhase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract CancerWho this might be right forBiliary Tract CancersIntrahepatic Cholangiocarcinoma (Icc)Extrahepatic Cholangiocarcinoma+3 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06918782What this trial is testingReal-world Experience With Combination Chemotherapy and Osimertinib in Poor Prognostic Group of Metastatic EGFR-mutated Lung AdenocarcinomaWho this might be right forLung Cancer (NSCLC) The University of Hong Kong 47
Testing effectiveness (Phase 2)Study completedNCT00818441What this trial is testingDacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The LungWho this might be right forCarcinoma, Non-small Cell Pfizer 119